Previous 10 | Next 10 |
Gainers: Synlogic (NASDAQ: SYBX ) +28% . Immuron (NASDAQ: IMRN ) +26% . B Communications (NASDAQ: BCOM ) +23% . Arcadia Biosciences (NASDAQ: RKDA ) +17% . Vuzix Corporation (NASDAQ: VUZI ) +14% . MagnaChip Semiconductor Corporation (NYSE: MX ) +13% . Osmotica Pharmaceuticals (N...
Thinly traded nano cap Immuron Limited ( IMRN +11.4% ) is up in early trade on the heels of encouraging results from a Shigella challenge study of in non-human primates aimed at assessing the effectiveness of Trevalen for preventing dysentery. More news on: Immuron Limited, Healthcar...
Key Highlights: Travelan ® shigellosis challenge studies in non-human primates successfully completed Travelan ® prevented clinical shigellosis (bacillary dysentery) in 75% of Travelan ® treated animals compared to placebo and demonstrated a significant...
MELBOURNE, Australia, May 30, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, today announced the closing of its ...
Gainers: Eltek (NASDAQ: ELTK ) +373% . Valeritas Holdings (NASDAQ: VLRX ) +40% . Soliton (NASDAQ: SOLY ) +34% . Technical Communications Corporation (NASDAQ: TCCO ) +30% . ReWalk Robotics (NASDAQ: RWLK ) +28% . Netshoes (Cayman) Limited (NYSE: NETS ) +19% . Cara Therapeutics (N...
Gainers: Avianca Holdings (NYSE: AVH ) +29% . Outlook Therapeutics (NASDAQ: OTLK ) +28% . Hibbett Sports (NASDAQ: HIBB ) +21% . Total System Services (NYSE: TSS ) +16% . Cavco Industries (NASDAQ: CVCO ) +16% . Biocept (NASDAQ: BIOC ) +13% . DASAN Zhone Solutions (NASDAQ: DZSI )...
Immuron (NASDAQ: IMRN ) has priced its public offering of 500K American Depositary Shares ((ADSs)) at $4.00 per ADS, for gross proceeds of $2M. More news on: Immuron Limited, Healthcare stocks news, Read more ...
MELBOURNE, Australia,, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, today announced the pricing of an ...
Australia's Immuron (NASDAQ: IMRN ) has announced a public offering of its American Depositary Shares . More news on: Immuron Limited, Healthcare stocks news, Global news and forex, Read more ...
MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for the treatment of gut mediated diseases, today announced that it intends to ...
News, Short Squeeze, Breakout and More Instantly...
Sales Highlights: MELBOURNE, Australia, July 15, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce record sales (unaudited) of Travelan ® , an over-the-counter immune ...
MELBOURNE, Australia, July 02, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce that it has filed a pre-IND (investigational new drug) application with the United States Food and Drug A...
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston has resigned from his position as Non-Executive Director effective today. Roger was appointed a...